TransIT-2020 transfection reagent released by Mirus Bio

NewsGuard 100/100 Score

From the transfection experts, Mirus Bio introduces its next generation transfection reagent, TransIT(R)-2020 Transfection Reagent.

Mirus has expanded its transfection expertise with the development of a high performance, animal-free, broad spectrum DNA transfection reagent which offers users:

  • Superior Performance--TransIT(R)-2020 outperforms FuGENE(R) HD, Lipofectamine(TM) 2000 and Lipofectamine(TM) 2000 CD in many cell types.
  • Broad Spectrum DNA Delivery--Achieve high transgene expression in many cell types, including hard to transfect cells.
  • Animal Origin free-- TransIT(R)-2020 provides high performance with maximum compatibility.
  • Scientifically Proven--Developed by Mirus Bio scientists with over 15 years of gene delivery expertise.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
Ancient Eastern Arabians developed malaria resistance through agriculture, study finds